Literature DB >> 2764384

Morphometric analysis of intraluminal mucus in airways in chronic obstructive pulmonary disease.

T Aikawa1, S Shimura, H Sasaki, T Takishima, H Yaegashi, T Takahashi.   

Abstract

Mucus volume in both central and peripheral airways was assessed in 13 patients, six with chronic bronchitis (CB) and seven with chronic pulmonary emphysema (CPE), by morphologic quantitative measurement in autopsied lungs, and the results were compared with those from four control lungs (NL). The patients with CB and CPE had severe obstructive impairment that did not differ significantly between the two groups (FEV1%, mean 45% in CB and mean 49% in CPE). Mucous hypersecretion during clinical remission differed significantly between the CB and CPE groups (mean 80 ml/day in CB and mean 8 ml/day in CPE). The length of the airway basement membrane and the area of mucus were measured with a digitizing computer. The volume ratio of mucus to airway lumen, which was defined as the volume ratio of mucus to airway lumen calculated as a cylinder by the length of basement membrane, was regarded as the mucus occupying ratio (MOR). MOR was significantly higher in CB lungs (4.1 +/- 1.0% in central airways and 19.6 +/- 3.8% in peripheral airways, mean +/- SE) than in NL (0.3 +/- 0.1% in central airways and 0.6 +/- 0.3% in peripheral airways, respectively) in both central and peripheral airways (p less than 0.05 and p less than 0.01, respectively), whereas no significant increase in MOR was found in CPE lungs, compared with NL. Furthermore, peripheral airway MOR was significantly higher than that of central airways in CB lungs (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2764384     DOI: 10.1164/ajrccm/140.2.477

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  11 in total

1.  Mucus strands from submucosal glands initiate mucociliary transport of large particles.

Authors:  Anthony J Fischer; Maria I Pino-Argumedo; Brieanna M Hilkin; Cullen R Shanrock; Nicholas D Gansemer; Anna L Chaly; Keyan Zarei; Patrick D Allen; Lynda S Ostedgaard; Eric A Hoffman; David A Stoltz; Michael J Welsh; Mahmoud H Abou Alaiwa
Journal:  JCI Insight       Date:  2019-01-10

Review 2.  The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease.

Authors:  Kian Fan Chung
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.

Authors:  Matthew R Murawski; Lori W McGinnes; Robert W Finberg; Evelyn A Kurt-Jones; Michael J Massare; Gale Smith; Penny M Heaton; Armando E Fraire; Trudy G Morrison
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

4.  Molecular cloning and sequencing of a canine tracheobronchial mucin cDNA containing a cysteine-rich domain.

Authors:  M Verma; E A Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

5.  Human bronchus and intestine express the same mucin gene.

Authors:  B H Jany; M W Gallup; P S Yan; J R Gum; Y S Kim; C B Basbaum
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

6.  A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD.

Authors:  Aran Singanayagam; Nicholas Glanville; Ross P Walton; Julia Aniscenko; Rebecca M Pearson; James W Pinkerton; Jay C Horvat; Philip M Hansbro; Nathan W Bartlett; Sebastian L Johnston
Journal:  Clin Sci (Lond)       Date:  2015-08       Impact factor: 6.124

7.  Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations.

Authors:  Aran Singanayagam; Nicholas Glanville; Jason L Girkin; Yee Man Ching; Andrea Marcellini; James D Porter; Marie Toussaint; Ross P Walton; Lydia J Finney; Julia Aniscenko; Jie Zhu; Maria-Belen Trujillo-Torralbo; Maria Adelaide Calderazzo; Chris Grainge; Su-Ling Loo; Punnam Chander Veerati; Prabuddha S Pathinayake; Kristy S Nichol; Andrew T Reid; Phillip L James; Roberto Solari; Peter A B Wark; Darryl A Knight; Miriam F Moffatt; William O Cookson; Michael R Edwards; Patrick Mallia; Nathan W Bartlett; Sebastian L Johnston
Journal:  Nat Commun       Date:  2018-06-08       Impact factor: 14.919

8.  Long acting beta2-agonist and corticosteroid restore airway glandular cell function altered by bacterial supernatant.

Authors:  Jean-Marie Zahm; Franck Delavoie; Férial Toumi; Béatrice Nawrocki-Raby; Claire Kileztky; Jean Michel; Gérard Balossier; Malcolm Johnson; Christelle Coraux; Philippe Birembaut
Journal:  Respir Res       Date:  2010-01-20

Review 9.  Cytokine inhibition in the treatment of COPD.

Authors:  Gaetano Caramori; Ian M Adcock; Antonino Di Stefano; Kian Fan Chung
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-04-28

Review 10.  Exacerbations of chronic obstructive pulmonary disease and chronic mucus hypersecretion.

Authors:  Yohannes Tesfaigzi; Paula Meek; Suzanne Lareau
Journal:  Clin Appl Immunol Rev       Date:  2006-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.